2.51
7.04%
-0.19
시장 영업 전:
2.54
0.03
+1.20%
Akoya Biosciences Inc 주식(AKYA)의 최신 뉴스
Akoya Biosciences unveils strategic product roadmap - Yahoo Finance
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels - GlobeNewswire
Revolutionary Neurobiology Panels: Akoya's New Weapon Against Brain Disease Research - StockTitan
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Significant Increase in Short Interest - MarketBeat
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner - Business Wire
Major Breakthrough: Akoya's Advanced Diagnostic Tech Gets Manufacturing Powerhouse Backing - StockTitan
Quanterix Nears All-Stock Deal for Akoya Biosciences - MSN
Spatial Proteomics Market Report and Competitive Landscape 2025-2030, with 10X Genomics, Bruker, Fluidigm, Akoya Biosciences, PerkinElmer, Biotechne, S2 Genomics, Seven Bridges Genomics & More - Yahoo Finance
Barclays PLC Buys 30,095 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Rating of “Hold” from Analysts - Defense World
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Jane Street Group LLC Decreases Stock Holdings in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences (NASDAQ:AKYA) Cut to Hold at Canaccord Genuity Group - Defense World
Akoya Biosciences (NASDAQ:AKYA) Downgraded by Canaccord Genuity Group to Hold - MarketBeat
Major Player in the Spatial Biology Market Analysis by Type, - openPR
Akoya Biosciences to be acquired by Billerica research firm, create $220M business - Worcester Business Journal
Quanterix merging with Akoya to bolster biomarker portfolio - BioWorld Online
Quanterix announces acquisition of Akoya Biosciences By Investing.com - Investing.com Canada
Quanterix announces acquisition of Akoya Biosciences - Investing.com
Billerica diagnostics maker Quanterix to acquire Marlborough biotech - The Business Journals
Akoya Biosciences (NASDAQ: AKYA) Enters Merger Agreement with Quanterix Corporation - Defense World
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders - GlobeNewswire Inc.
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ESSA, AKYA, CCNE, QTRX on Behalf of Shareholders - The Malaysian Reserve
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerACCD, QTRX, AKYA, ESSA - Markets Insider
Quanterix Agrees to Buy Life Sciences Firm Akoya Biosciences - MSN
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc.AKYA - Business Wire
Quanterix Is Close to All-Stock Deal for Akoya Bioscience - MSN
Akoya climbs after merger deal with Quanterix - MSN
Shareholder Alert: Ademi LLP Investigates Whether Akoya Biosciences, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
AKYA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akoya Biosciences, Inc. Is Fair to Shareholders - Business Wire
Quanterix to acquire Akoya Biosciences in an all-stock transaction - TipRanks
Akoya stock climbs after Quanterix merger deal (AKYA:NASDAQ) - Seeking Alpha
Major Player in the Spatial Proteomics Market 20252032 - openPR
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers - Business Wire
A Data-Based Look At Akoya Biosciences Inc (AKYA) - Stocks Register
State Street Corp Boosts Position in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Grows By 20.7% - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of “Hold” by Analysts - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 20.7% in December - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares Sold by HighTower Advisors LLC - Defense World
Charles Schwab Investment Management Inc. Decreases Stake in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences updates director and officer indemnification agreements By Investing.com - Investing.com Canada
Akoya Biosciences updates director and officer indemnification agreements - Investing.com India
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 18.1% in November - Defense World
Market Cool On Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Pushing Shares 29% Lower - Simply Wall St
자본화:
|
볼륨(24시간):